Sign in

CIK 0001783183 · Non-accelerated filer<br>Smaller reporting company

Phathom Pharmaceuticals, Inc.

Sign in to watch
Ticker
PHAT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
824151574
Phone
(877) 742-8466
Business address
100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-05-13 Curran Terrie President and Chief Executive Purchase +20,500 $7.41 $152K 64,595
2022-05-13 Henderson Molly CFO and CBO Purchase +6,000 26,000
2022-05-12 Parikh Asit Director Purchase +12,500 $8.00 $100K 12,500
2020-04-01 RA CAPITAL MANAGEMENT, L.P. 10% owner Purchase +117,600 $24.86 $2.9M 3,825,008
2020-03-31 RA CAPITAL MANAGEMENT, L.P. 10% owner Purchase +30,600 $24.55 $751K 3,707,408
2020-03-27 RA CAPITAL MANAGEMENT, L.P. 10% owner Purchase +30,000 $24.60 $738K 3,676,808
2019-10-29 COLA MICHAEL F Director Purchase +9,798 $19.00 $186K 9,798
2019-10-29 Edwards Jonathan S. Director Purchase +1,028,205 $19.00 $19.5M 2,019,877
2019-10-29 Edwards Jonathan S. Director Purchase +24,426 $19.00 $464K 47,984
2019-10-29 Frazier Life Sciences IX, L.P. 10% owner Purchase +1,052,631 $19.00 $20.0M 7,284,269

Page 2 of 2 · 30 trades